| James Baptiste, REGISTERED NURSE | |
|
50 Division St, Suite 101, Somerville, NJ 08876-2943 | |
| (973) 932-8795 | |
| Not Available |
| Full Name | James Baptiste |
|---|---|
| Gender | Male |
| Speciality | Home Health |
| Location | 50 Division St, Somerville, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124490636 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 26NR16070800 (New Jersey) | Secondary |
| 251E00000X | Home Health | 26NR16070800 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Baptiste, REGISTERED NURSE 50 Division St, Suite 101, Somerville, NJ 08876-2943 Ph: (973) 932-8795 | James Baptiste, REGISTERED NURSE 50 Division St, Suite 101, Somerville, NJ 08876-2943 Ph: (973) 932-8795 |
News Archive
Researchers have identified an important cancer gene that could lead to more effective drugs being developed to fight paediatric high grade glioma, a disease which currently has a poor prognosis.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications related to its rapid prototyping system for the manufacture of microfluidic chips, or Lab-on-a-Chip (LOC) devices, have been filed.
It's known that racial minorities in the United States undergo fewer total knee replacements (TKRs) for knee osteoarthritis, but it's unclear how this affects their quality of life.
Now, based on the final results of a nationwide study led by UCLA, clinicians may be able to accurately predict within a week whether a particular drug will be effective by using a non-invasive test that takes less than 15 minutes to administer. The test will allow physicians to quickly switch patients to a more effective treatment, if necessary.
In a guest column for the New Jersey Star-Ledger, a former White House spokesman and Chief-of-Staff for the House Aging Committee and Health Subcommittee, Robert Weiner, a George Washington University breast cancer laboratory director and professor, Dr. Patricia Berg, and policy analyst, James Lewis assert that "as the government keeps funding two wars and ongoing tax breaks, curing diseases like cancer is being threatened in the budget debates underway.
› Verified 2 days ago